Phase 3 CLI Clinical Proceed with Special Protocol Assessment, Aastrom (ASTM)
July 6th, 2010
No comments
ASTM will pursue a Phase 3 clinical program for its autologous cell therapy for the treatment of critical limb ischemia (CLI) through the FDA’s special protocol assessment (SPA) process. Read more…
